Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Forloni

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Journal of Internal Medicine|March 5, 2016
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.
Neurology|February 19, 2010
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutationA C Bruni, L Bernardi, R Colao, et al.
Neurology|December 24, 2010
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriersN Finch, M M Carrasquillo, M Baker, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Journal of Internal Medicine|March 5, 2016
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'S Galluzzi, M Marizzoni, C Babiloni, et al.
Neurology|February 19, 2010
Worldwide distribution of PSEN1 Met146Leu mutation: a large variability for a founder mutationA C Bruni, L Bernardi, R Colao, et al.
Neurology|December 24, 2010
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriersN Finch, M M Carrasquillo, M Baker, et al.
Pageof 10